AstraZeneca to discover new drugs through ‘open innovation’

Published: 2018-07-19 15:32:35

Updated: 2018-07-19 15:32:35

Multinational pharmaceutical company AstraZeneca seems to expand its pipelines by actively taking open innovation activities to develop new drugs.

AstraZeneca Korea held the ‘ASK AZK 2018’ with medical journalists on the 16^th and announced this.

According to AstraZeneca, the company has strengthen communication with the outside of the company through the ‘IMED’ portal which provides informati...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.